AOD-9604 — Targeted Fat-Loss Peptide
Lipolysis activation • Fat-cell reduction • Metabolic support
AOD-9604 is a modified fragment of human growth hormone engineered specifically to target fat metabolism — without stimulating overall growth hormone or IGF-1 levels. This makes it a unique compound in metabolic research because it delivers the fat-burning effects of GH without the anabolic or endocrine impact.
In research and clinical environments, AOD-9604 has been shown to:
• Stimulate lipolysis (fat breakdown)
• Inhibit lipogenesis (new fat storage)
• Target stubborn fat deposits
• Support metabolic efficiency
• Reduce fat cell size and number
Unlike GLP-1 peptides that suppress appetite, AOD-9604 works by directly signaling fat cells to release stored energy, making it a powerful tool in body-recomposition and fat-loss research.
Why AOD-9604 is different
AOD-9604 does not affect hunger, insulin, or hormones —
it communicates directly with fat tissue.
By activating the same lipolytic pathways as growth hormone, it allows the body to:
• Mobilize stubborn fat
• Prevent new fat formation
• Improve body composition
• Enhance metabolic output
This makes it especially valuable in plateau-breaking and visceral fat research.
Used in research to study
• Obesity and metabolic dysfunction
• Fat-cell signaling
• Body recomposition
• Lipid metabolism
• Weight-management strategies
PHP™ Research Performance Standard
Our AOD-9604 is supplied as a research-grade lyophilized peptide produced in GMP-certified facilities and verified for:
✔ Identity
✔ Purity
✔ Potency
✔ Endotoxin levels
Because real performance starts at the cellular level.
Pure Science. Raw Power.